1. Home
  2. QUAD vs PEPG Comparison

QUAD vs PEPG Comparison

Compare QUAD & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quad Graphics Inc

QUAD

Quad Graphics Inc

HOLD

Current Price

$6.32

Market Cap

305.8M

ML Signal

HOLD

Logo PepGen Inc.

PEPG

PepGen Inc.

HOLD

Current Price

$4.48

Market Cap

317.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUAD
PEPG
Founded
1971
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Publishing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
305.8M
317.6M
IPO Year
2010
2022

Fundamental Metrics

Financial Performance
Metric
QUAD
PEPG
Price
$6.32
$4.48
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$9.10
$10.80
AVG Volume (30 Days)
123.2K
688.1K
Earning Date
02-17-2026
02-23-2026
Dividend Yield
4.85%
N/A
EPS Growth
N/A
N/A
EPS
0.42
N/A
Revenue
$2,497,700,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$14.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.50
$0.88
52 Week High
$8.04
$7.80

Technical Indicators

Market Signals
Indicator
QUAD
PEPG
Relative Strength Index (RSI) 52.88 36.65
Support Level $6.08 $4.20
Resistance Level $6.38 $5.46
Average True Range (ATR) 0.19 0.49
MACD 0.01 -0.12
Stochastic Oscillator 67.27 8.73

Price Performance

Historical Comparison
QUAD
PEPG

About QUAD Quad Graphics Inc

Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America and others countries. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market..

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

Share on Social Networks: